The Hospital of the Future with discussants David Eddy, Joe Hogan, John Maeda and Ken Weakley at the 2007 Aspen Health Forum. Harvey Fineberg moderates.
Imagine patient rooms replete with wireless technology, "smart systems" that help avoid human error, and built environments designed to heighten personal care. Will the hospital of tomorrow even resemble the hospitals of today? What would it look like if George Jetson got sick? And how long before we realize such innovations?- Aspen Institute
David Eddy is Founder and Chief Medical Officer of Archimedes Inc., a comprehensive simulation model of health care developed at Kaiser Permanente. More than 25 years ago, Dr. Eddy wrote the seminal paper on the role of guidelines in medical decision making, the first Markov model applied to clinical problems, the original criteria for coverage decisions, and was the first to use and publish the term "evidence-based."
He is the author of five books, more than 100 first-authored articles, and a series of essays for the Journal of the American Medical Association. Dr. Eddy received his MD from the University of Virginia and his PhD in engineering-economic systems (applied mathematics) from Stanford University.
Harvey V. Fineberg
Harvey V. Fineberg is President of the Institute of Medicine. He served as Provost of Harvard University from 1997 to 2001, after thirteen years as Dean of the Harvard School of Public Health. Dr. Fineberg helped found and later served as President of the Society for Medical Decision Making. He is the co-author of the books Clinical Decision Analysis, Innovators in Physician Education, and The Epidemic that Never Was, an analysis of the controversial federal immunization program against swine flu in 1976.
He also co-edited several books, and has written numerous articles published in professional journals. He is the recipient of the Joseph W. Mountain Prize and the Wade Hampton Frost Prize. Dr. Fineberg received his bachelor's and professional degrees at Harvard University.
Joseph M. Hogan is President and Chief Executive Officer of GE Healthcare, a position he has held since November 2000. Formerly US-based GE Medical Systems, GE Healthcare is now a $17 billion global business and the only GE business headquartered outside the United States. During his tenure at GE Healthcare, the business has more than doubled in revenue and has been transformed into the leading diagnostics, information technology and life sciences company worldwide.
Mr. Hogan began his career at GE in 1985 and advanced through a series of leadership roles at GE Plastics in sales, marketing and product management. In March 1998, he was named President and Chief Executive Officer of GE Fanuc Automation North America, Inc., a global supplier of industrial controls systems. Mr. Hogan sits on the Boards of the New York Academy of Medicine, the Multiple Myeloma Research Foundation, the Advisory Board of the Center for Disease Control (CDC) and Advamed.
John Maeda is Partner at Kleiner Perkins Caufield and Byers, where he works with KPCB’s entrepreneurs and portfolio companies to build design into their company cultures. He served as the 16th president of Rhode Island School of Design (RISD) from 2008 through 2013, during which time RISD saw increased applications, fundraising, and career placements. Prior to RISD, Maeda spent 13 years at the MIT Media Lab as a professor and head of research. His career bridging the intersections of graphic design, computer science, art, education, and leadership earned him the distinction of being named one of the 75 most influential people of the 21st century by Esquire. Maeda chairs the eBay Design Advisory Council, serves on the boards of the wireless hi-fi company Sonos and the advertising agency Wieden+Kennedy, and is a member of the World Economic Forum's Global Agenda Council on New Models of Leadership. His books include The Laws of Simplicity, Creative Code, and Redesigning Leadership, which expands on his Twitter feed at @johnmaeda, one of TIME Magazine’s 140 Best Twitter Feeds. He has received a variety of international awards for his creative work, including induction to the Art Director's Club Hall of Fame and the White House's National Design Award.
Michelle McMurry is Director of the Health, Biomedical Science, and Society Policy Program and the Aspen Health Forum at the Aspen Institute. She trained in pediatrics and molecular immunology. Since transitioning into health and science policy, her work has focused on the intersection of biomedical research funding policies and healthcare disparities and global health inequities. She has been a Global Health Fellow at the Council for Foreign Relations and is an Adjunct Assistant Professor of Health Policy at George Washington University.
She was formerly a Robert Wood Johnson Health and Society Scholar at the University of California at Berkeley and San Francisco. She formerly oversaw health and social policy issues for Senator Joseph Lieberman and was the senior health policy advisor for the Lieberman for President Campaign. She also worked to improve diversity in graduate science education in the Office of the Director of the National Science Foundation as an AAAS Science Policy Fellow.
Kenneth Weakley is a Managing Director of Credit Suisse in the Equity Research Department within the Investment Banking Division, responsible for covering health care facilities companies. Prior to joining Credit Suisse in July 2007, Mr. Weakley worked at UBS Investment Research.
He has been covering health care facilities companies for more than 12 years, and has been recognized by Institutional Investor and Greenwich Associates as a leading health care facilities analyst. He holds a bachelor's in economics and a bachelor's in business from Rhode Island College, and an MBA from the State University of New York Buffalo.